TRENTON, N.J. | Drugmaker to sell cheaper generic rival to EpiPen injectors

6Dec - by Editor - 0 - In STL.News



TRENTON, N.J.  — Generic drugmaker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

The penlike injectors are used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.

Sandoz will sell a pair of injectors, under the name Symjepi, for $250 without insurance.

Continue reading TRENTON, N.J. | Drugmaker to sell cheaper generic rival to EpiPen injectors at STL.News.



Source link